Good morning :)
$
₹
Enovis Corp

Enovis Corp

ENOV

NYSE
Asset Logo

Enovis Corp

ENOV

NYSE
$18.554.36% (-0.84)
$
₹
$18.554.36% (-0.84)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Small Cap

With a market cap of $1.2B the stock is ranked 2672

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.80
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-18.96
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.89
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-47.97%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 11 analysts' reports

Buy
10 analysts
Hold
1 analyst
Sell
0 analyst

Analysts expect a +106.54% price upside over the next year

Current Price$18.55
Target Price$38.33

Company Profile

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
—
—
P/E Ratio
35.18
35.18
—
—
1Y Return
17.72%
17.72%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
—
—
P/E Ratio
36.89
36.89
—
—
1Y Return
4.52%
4.52%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
—
—
P/E Ratio
42.35
42.35
—
—
1Y Return
19.32%
19.32%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
—
—
P/E Ratio
32.89
32.89
—
—
1Y Return
22.95%
22.95%
Buy Reco %
68.75
68.75
Medtronic PLC
MDT
Medtronic PLC
—
—
P/E Ratio
24.71
24.71
—
—
1Y Return
2.19%
2.19%
Buy Reco %
53.12
53.12

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Enovis Corp -0.801.89
Abbott Laboratories35.183.681.99
Danaher Corporation36.892.851.39

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

548.9
-571.1
575.7
-520.5
589.1
-8.7
582.7
-1.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue516.26525.16505.22560.97558.83564.54548.91575.75589.15582.78
Net Income-71.99-18.63-31.52-703.33-55.96-36.73-571.14-520.58-8.76-1.19
Net Profit Margin-13.94%-3.54%-6.23%-125.37%-10.01%-6.50%-104.05%-90.41%-1.48%-0.20%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Enovis Corp (ENOV) share price today is $18.55 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $19.30 and a day low of $18.54.

  2. Enovis Corp stock trades on NYSE under the ticker symbol ENOV.

  3. Enovis Corp's market capitalization is $1.16B as of September 5, 2026 at 1:30 AM IST.

  4. Enovis Corp's price-to-earnings (P/E) ratio is N/A as of September 4, 2026.

  5. Enovis Corp's price-to-book (P/B) ratio is 0.80 as of September 4, 2026.

  6. Yes, You can buy Enovis Corp shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Enovis Corp shares in three steps: 1. Search Enovis Corp on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Enovis Corp trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Enovis Corp (ENOV) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.5389 shares at the current price of $18.55.

Loading...